Stock 4559 ZERIA PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Zeria Pharmaceutical Co., Ltd.

Equities

4559

JP3428850006

Delayed Japan Exchange
Other stock markets
 06:11:49 26/06/2024 BST 		5-day change 1st Jan Change
2,098 JPY +0.91% Intraday chart for Zeria Pharmaceutical Co., Ltd. +0.82% +3.97%
06-03 Zeria Pharmaceutical's Attributable Profit Soars 24.8% in Fiscal 2024 MT
05-09 Zeria Pharmaceutical Co., Ltd. Announces Year End Dividend for the Full Year Ending March 31, 2024, Payable on June 28, 2024 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Zeria Pharmaceutical's Attributable Profit Soars 24.8% in Fiscal 2024
MT
Zeria Pharmaceutical Co., Ltd. Announces Year End Dividend for the Full Year Ending March 31, 2024, Payable on June 28, 2024
CI
Zeria Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the First Six Months and Full Year Ending March 31, 2025
CI
Zeria Pharmaceutical Co., Ltd. Provides Second Quarter and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2025
CI
Borsch Med Pte. Ltd. Introduces Chondroitin Supplements of Zeria Pharmaceutical Co. Ltd to Singapore for Healthy Joints
CI
Final dividend
FA
Zeria Pharmaceutical's Profit Up 41% in Fiscal Q1-Q3
MT
Japanese Shares End Firmer on Friday on BoJ Policy Outlook
MT
Zeria Pharmaceutical Books Higher Fiscal H1 Attributable Profit on Loss Provision Reversal
MT
Zeria Pharmaceutical Co., Ltd. Announces Dividend for the Second Quarter of Fiscal Year Ending March 31, 2024, Payable on December 1, 2023
CI
Zeria Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2024
CI
Ex-dividend day for interim dividend
FA
Zeria Pharmaceutical’s Attributable Profit Up 12.1% in Fiscal Q1 on Absence of Forex Losses
MT
Zeria Pharmaceutical Co., Ltd. Provides Dividend Forecast for the Fiscal Year Ending March 31, 2024
CI
Zeria Pharmaceutical Co., Ltd. Provides Consolidated Financial Forecast for the Six Months of 2024 and the Fiscal Year Ending March 31, 2024
CI
Zeria Pharmaceutical Co., Ltd. Provides Dividend Forecast for the Second Quarter of 2024
CI
Zeria Pharmaceutical : 69th Business Report (From April 1, 2022 to March 31, 2023.)
PU
Zeria Pharmaceutical : Notice of the 69th Ordinary Stockholders' General Assembly
PU
Tranche Update on Zeria Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2022.
CI
Zeria Pharmaceutical Co., Ltd.'s Equity Buyback announced on May 11, 2022, has closed with 263,900 shares, representing 0.6% for ¥545.29 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4559 Stock
  4. News Zeria Pharmaceutical Co., Ltd.